Estrella Immunopharma, Inc. ESLA

0.48 0.01 2.13% as of 25 Sep

Follow ESLA

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	199.78%	255.59%	373.21%	148.05%
ROA Full definition →		(250.19%)	(413.55%)	(434.36%)	(416.74%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		80.10%	110.09%	195.73%	134.74%
Free Cash Flow per Share Full definition →		0.05	(0.05)	(0.19)	(0.22)
Free Cash Flow Full definition →		2.02	(1.79)	(8.02)	(9.38)
Piotroski F-Score Full definition →		2.00	1.00	2.00	2.00
Other line items
Cash ROIC Full definition →		(24.63%)	19.88%	239.84%	128.81%
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		(0.22)	0.14	0.61	0.94
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		0.05	(0.05)	(0.19)	(0.22)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Net Profit Margin Full definition →		0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack